Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2006; 12(10): 1607-1612
Published online Mar 14, 2006. doi: 10.3748/wjg.v12.i10.1607
Published online Mar 14, 2006. doi: 10.3748/wjg.v12.i10.1607
Table 1 Laboratory characteristics of patients investigated according to the stage of disease1
| Stage | I | II | III | IV |
| Patients (n°) | 12 | 11 | 15 | 13 |
| Alkaline phosphatase (U/L | 273 (50-797) | 447 (145-1315) | 397 (190-1956) | 289 (52-1960) |
| AST (U/L) | 28 (13-6) | 38 (25-400) | 35 (14-63) | 49 (11-144) |
| ALT (U/L) | 37 (14-89) | 54 (17-100) | 39 (17-72) | 47 (8-218) |
| Total Bilirubin (mg/dL) | 0.7 (0.4-2.4) | 0.9 (0.2-1.2) | 0.9 (0.3-1.5) | 1.0 (0.5-1.6) |
| Cholesterol (mg/dL) | 190 (112-235) | 220 (104-285) | 219 (110-275) | 208 (154-314) |
| aPTT (sec) | 32 (27-63) | 28 (26-43) | 32 (25-37) | 32 (26-36) |
| PT (%) | 98 (90-105) | 100 (91-120) | 99 (81-100) | 93 (58-100) |
| Fibrinogen (mg/dL) | 379 (279-650) | 380 (268-463) | 327 (276-590) | 380 (100-586) |
- Citation: Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J Gastroenterol 2006; 12(10): 1607-1612
- URL: https://www.wjgnet.com/1007-9327/full/v12/i10/1607.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i10.1607